Delivery Order SPE2DB20D9226-SPE2DB21FQ62H
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $8,576.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG implants, a contraceptive product, with a performance period extending through April 5, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, which has a ceiling value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,409.76 firm fixed-price delivery order is for the supply of NEXPLANON 68 mg implants, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
- This $1,429.38 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a completion date of August 27, 2024. DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025....
- This federal contract award, valued at $3,775.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,553.90 contract is for the delivery of 68 mg NEXPLANON implants, which are contraceptive devices, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,881.40 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with an ultimate completion date of September 20, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $3,074.80 for the provision of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which has a total potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the supply of 4565775288 NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 firm fixed-price delivery order contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract has an ultimate completion date of August 6, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC)...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB21FQ62HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,226.48 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with an ultimate completion date of August 25, 2021. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/4/21 |